Chorea
Search documents
Will Forte Teams Up with Teva to Get Real About Huntington's Disease with ‘Honestly HD'
Globenewswire· 2026-01-27 13:00
Company Overview - Teva Pharmaceuticals is a leading innovative biopharmaceutical company with a strong generics business, committed to improving health for over 120 years [5] - The company focuses on neuroscience, immunology, complex generic medicines, biosimilars, and pharmacy brands globally [5] Partnership and Advocacy - Teva Pharmaceuticals announced a partnership with actor Will Forte to raise awareness about Huntington's disease (HD), which affects over 41,000 people in the U.S. [1][3] - Will Forte shares his family's experience with HD to connect individuals affected by the disease with educational resources and support [1][3] Huntington's Disease (HD) Insights - HD is a rare, progressive neurological disorder characterized by cognitive, behavioral, and physical challenges, including chorea, which affects about 90% of patients [3][6] - Chorea manifests as involuntary movements that can significantly impact daily life and limit individuals' independence [3][7] Community Engagement - Teva emphasizes the importance of understanding the real experiences of the HD community to foster empathy and awareness [4] - The Honestly HD program aims to provide educational information about HD and support for those living with the condition and their caregivers [7]